UroToday

The Current Status of Prostate Artery Embolization (PAE) for the Treatment of Benign Prostatic Hyperplasia (BPH).

Prostatic artery embolization (PAE) has become established as a minimally invasive treatment option for benign prostatic hyperplasia (BPH) in recent years. This review aims to provide a coherent ...
Frontiers

Preclinical evaluation of waste-derived pomegranate extract (PWE) as a potential preventing and therapeutic agent for benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH) is a highly prevalent age-related condition, affecting nearly half of men over 60 and up to 80% over 80 years old. Chronic inflammation and oxidative stress are ...
UroToday

Feasibility of Holmium Laser Enucleation of the Prostate (HoLEP) after Prior Prostate Intervention for Benign Prostatic Hyperplasia (BPH) - Beyond the Abstract

Multiple minimally invasive procedures are available for treating enlarged prostate and lower urinary tract symptoms (LUTS), including TURP, PAE, HoLEP, Green light laser (PVP), THuLEP, PUL, iTind™, ...